Health News Releases

  • Today February 18
April 04, 2016 09:00
Samsung Bioepis' Flixabi® Infliximab Biosimilar Recommended for Approval in the European Union
Samsung Bioepis Co., Ltd. today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion on Flixabi® - a biosimilar ver
April 01, 2016 12:00
New Clinical Study Reports Relationship Between Masimo’s Oxygen Reserve Index (ORI™) and Arterial Partial Pressure of Oxygen During Surgery
Masimo (NASDAQ: MASI) announced today that a new retrospective study reports the relationship between Masimo’s Oxygen Reserve Index (ORI™) and arterial partial pressure of oxygen (PaO2) during surgery
March 31, 2016 15:00
Gore Launches Unique Biomaterial for Complex Ventral Hernia Repair
W. L. Gore & Associates, Inc. (Gore) today announced the launch of GORE® SYNECOR Biomaterial, a unique hybrid device for hernia repair, at the 17th Annual Hernia Repair Conference held March 30-April
March 31, 2016 13:40
Quantel Medical Awarded Tender for Ophthalmic Laser Equipment from India Department of Defense
Quantel Medical (Quantel), a global ophthalmic medical device company dedicated to developing leading technologies to improve the diagnosis and treatment of ocular diseases, announced it has been awar
March 24, 2016 15:35
Quintiles Honored as ‘Best CRO in Asia’ for Fourth Time in Six Years
Quintiles last night was named the “Best CRO in Asia” at the 2016 BioPharma Asia Industry Awards, winning the honor for the fourth time in the event’s six-year history. The award goes to the contract
March 24, 2016 10:50
Boehringer Ingelheim launches RE-COVERY DVT/PE™: global observational study on management of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) with Pradaxa® (dabigatran etexilate)
Boehringer Ingelheim today announces the enrollment of the first patient in RE-COVERY DVT/PE™, a global observational study on the management of blood clots in the legs (deep vein thrombosis, DVT) and
March 21, 2016 13:15
Oral Ozanimod Showed Histologic Improvements in Patients with Ulcerative Colitis in the Phase 2 TOUCHSTONE Trial
Celgene International Sàrl, a wholly owned subsidiary of Celgene Corporation (NASDAQ: CELG), today announced that additional data of exploratory endpoints from the TOUCHSTONE phase 2 clinical trial of
March 21, 2016 13:05
Ferring Pharmaceuticals: Wake up to Nocturia: the Most Common Cause of Disrupted Sleep That Could Be Damaging Your Health
Today is ‘World Sleep Day’ which was initiated by the World Association of Sleep Medicine (WASM) to acknowledge the importance of a good night’s sleep and the impact of sleep on health and quality of
March 21, 2016 10:00
Apira Science’s iGrow Becomes First Hair Growth Device Cleared by China Food and Drug Administration (CFDA)
Apira Science, Inc. continues its global expansion, receiving clearance for the iGrow Hair Growth System in China. The iGrow is now the only hair growth device to receive clearance from the China Food
March 18, 2016 16:47
Give Your Body a Boost with the Power-Packed Cranberry
Finding new ways to refresh your eating routine can be tricky and time-consuming, especially if you’re trying to pack more fruits and vegetables into your day. If you’re looking for a fruit that works
March 18, 2016 15:39
HOYA Group Appoints Gerald W. Bottero Global President of PENTAX Medical
PENTAX Medical, a division of HOYA Group, has announced the appointment of Gerald W. Bottero to the position of Global President of PENTAX Medical as of February 1st, 2016. “HOYA Group is pleased t
March 17, 2016 14:35
SRS Medical Receives Approval for Use of Spanner Prostate Stent in South Korea
SRS Medical Systems, Inc., today announced that it has received approval from the Korea Food and Drug Administration (KFDA) for broad use of its Spanner® Temporary Prostatic Stent in South Korea. The
March 16, 2016 14:20
Publication in Retrovirology of the results of Biosantech's phase IIA clinical trial for the anti-HIV candidate vaccine
The detailed results of the phase IIA clinical trial of Biosantech's candidate anti-HIV vaccine, its main objective being to demonstrate a reduction in the viremic recovery as well as in the pro-viral
March 16, 2016 13:50
ANGUS Unveils a New Division: ANGUS Life Sciences
ANGUS Chemical Company, a leading manufacturer and marketer of nitroalkanes and their derivatives, today announced the launch of its new life sciences division, ANGUS Life Sciences. Formed to provide
March 15, 2016 16:40
Takeda and Frazier Healthcare Partners Launch Outpost Medicine to Develop New Therapeutics in Urology and Gynecology
Takeda Pharmaceutical Company Limited (TOKYO:4502) and Frazier Healthcare Partners today announced the formation of Outpost Medicine, a biopharmaceutical company focused on the development of new trea
March 14, 2016 10:30
Mannatech’s Ambrotose® Powders May Enhance Video Game Player Performance
Mannatech, Incorporated (NASDAQ: MTEX) (http://goo.gl/SP6Q2G), the founder of the M5MSM (Mission 5 MillionSM) Foundation (http://goo.gl/HIWBRe), the pioneer of Glyconutrition and the global innovator
March 09, 2016 11:30
Octapharma Group Publishes 2015 Annual Results Reporting Revenue of €1.5 Billion and Operating Income of €351 Million
The Octapharma Group publishes its 2015 annual results reporting revenue of 1.513 billion Euro, representing an increase of 233 million Euro or 18.2% compared with the 2014 figure. Gross profit in
March 08, 2016 22:00
Crown Bioscience Acquires PreClinOmics, Expands Cardiovascular and Metabolic Disease Portfolio
Crown Bioscience, Inc., a wholly owned subsidiary of Crown Bioscience International (TWSE:ticker 6554), a global drug discovery and development solutions company providing translational platforms to a
March 08, 2016 18:00
New Analyses: Adding SPIRIVA® Respimat® Effective for Uncontrolled Asthma - Regardless of Allergy Subtype[1,2,3]
Boehringer Ingelheim today announced the presentation of new post-hoc analyses that show the addition of SPIRIVA® (tiotropium) Respimat® to other asthma maintenance therapies helps improve lung functi
March 08, 2016 14:35
Seegene Technologies to Unleash Customized Multiplex PCR Solutions and Support for U.S. Market
Seegene Technologies, Inc., a wholly-owned subsidiary of Seegene, Inc. (096530. KQ) (http://goo.gl/SCVQW1), a global developer of multiplex molecular technologies and multiplex clinical molecular diag
March 08, 2016 12:15
Oral OTEZLA® (Apremilast) Long-Term Safety Data Presented at American Academy of Dermatology Congress
Celgene Corporation (NASDAQ: CELG) today announced that long-term safety findings from ongoing clinical trials of OTEZLA® (apremilast), the Company‘s oral, selective inhibitor of phosphodiesterase 4 (
March 08, 2016 12:10
AbbVie and Boehringer Ingelheim announce global collaboration on promising immunology compounds
AbbVie (NYSE:ABBV) and Boehringer Ingelheim today announced a global collaboration to develop and commercialize BI 655066, an anti-IL-23 monoclonal biologic antibody in Phase 3 development for psorias
March 08, 2016 12:00
Quintiles Named as a 2016 World’s Most Ethical Company by the Ethisphere Institute
Quintiles, the world’s largest provider of product development and integrated healthcare services, has been recognized by the Ethisphere Institute, a global leader in defining and advancing the standa
March 07, 2016 11:15
Quintiles and the American College of Surgeons Announce Agreement to Develop Clinical Registry of the Future
Quintiles and the American College of Surgeons (ACS) today announced a six-year strategic services agreement to improve data collection and quality reporting for all ACS clinical registries. Working t
March 07, 2016 10:05
Oral OTEZLA® (apremilast) Data from Open-Label Phase of ESTEEM and LIBERATE™ Trials to Be Presented at American Academy of Dermatology Congress
Celgene Corporation (NASDAQ:CELG) today announced that findings from ongoing clinical trials of OTEZLA® (apremilast), the Company's oral, selective inhibitor of phosphodiesterase 4 (PDE4), in patients
25 per page50 per page75 per page100 per page